Jul 27, 2024, 08:53
ASCO’s rapid guideline update on the management of stage III NSCLC
American Society of Clinical Oncology (ASCO) shared a post on X:
“For more on our recent rapid guideline update on the management of stage III NSCLC, based on the results of the phase 3 LAURA trial, ASCO Daily News has a detailed analysis and an interview with Expert Panel co-chair Navneet Singh.
Source: ASCO/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19